Personal information

Emails & domains

Verified email addresses

Verified email domains

Websites & social links

LinkedIn

Keywords

Cardiovascular Diseases, Epidemiology, Risk Prediction

Countries

Myanmar [Burma], Switzerland

Activities

Collapse all

Employment (3)

Centre Hospitalier Universitaire Vaudois: Lausanne, CH

2022-09-01 to present | Research Fellow (Service de médecine interne)
Employment
Source: Self-asserted source
Ko Ko Maung

Asia Royal hospital : Yangon, MM

2019-11-01 to 2022-07-31 | Medical Officer (Medical, Cardiac, Emergency, Teleconsultation)
Employment
Source: Self-asserted source
Ko Ko Maung

University Of Medicine 1 Yangon: Yangon, MM

2018-01-01 to 2019-01-01 | Internship (Emergency, Medical, Surgical, Obstetrics and gynaecology and Pediatrics wards)
Employment
Source: Self-asserted source
Ko Ko Maung

Education and qualifications (3)

General Medical Council: London, GB

2023-03 | Professional and Linguistic Assessments Board (PLAB 1 + 2)
Qualification
Source: Self-asserted source
Ko Ko Maung

University Of Medicine 1 Yangon: Yangon, MM

2019-03-02 | M.B., B.S.
Education
Source: Self-asserted source
Ko Ko Maung

London Chamber of Commerce and Industry: London, GB

2012-11 | Diploma in Business Statistics, Accounting, Advanced Business Calculations, Cost Accounting, Management Accounting
Qualification
Source: Self-asserted source
Ko Ko Maung

Professional activities (1)

European Society of Cardiology: Biot, FR

2022-12-19 to 2023-12-19 | Silver Member (European Association of Preventive Cardiology)
Membership
Source: Self-asserted source
Ko Ko Maung

Funding (1)

SWISS GOVERNMENT EXCELLENCE SCHOLARSHIP

2022-09 to 2023-10 | Grant
Swiss Government Excellence (Lausanne, CH)
Source: Self-asserted source
Ko Ko Maung

Works (6)

Trends in potentially avoidable hospitalizations for diabetes in Switzerland, 1998 to 2018: Data from multiple cross-sectional studies

Heliyon
2024-12 | Journal article
DOI: 10.1016/j.heliyon.2024.e40466
Contributors: Ko Ko Maung; Charlène Mauron; Alexandre Gouveia; Pedro Marques-Vidal
Source: check_circle
Crossref

Trends in Avoidable Hospitalizations for Heart Failure in Switzerland (1998–2018): A Cross-Sectional Analysis

Healthcare
2024-12-17 | Journal article
DOI: 10.3390/healthcare12242547
Contributors: Lionel Gaillard; Ko Ko Maung; Charlène Mauron; Pedro Marques-Vidal; Alexandre Gouveia
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Twenty-year trends of potentially avoidable hospitalizations for hypertension in Switzerland

Hypertension Research
2024-10 | Journal article
DOI: 10.1038/s41440-024-01853-x
Contributors: Pedro Marques-Vidal; Ko Ko Maung; Alexandre Gouveia
Source: check_circle
Crossref

Reported recommendations to address cardiovascular risk factors differ by socio-economic status in Brazil. Results from the Brazilian National Health Survey 2019

Preventive Medicine Reports
2023-11 | Journal article
DOI: 10.1016/j.pmedr.2023.102527
Part of ISSN: 2211-3355
Contributors: Patriota, P; Ko Ko Maung; Pedro Marques-Vidal
Source: Self-asserted source
Ko Ko Maung

Impact of the COVID-19 pandemic on CVD prevention between different socioeconomic groups in Switzerland

Open Heart
2023-09 | Journal article
DOI: 10.1136/openhrt-2023-002368
Contributors: Ko Ko Maung; Pedro Marques-Vidal
Source: check_circle
Crossref

Impact of COVID-19 pandemic on cardiovascular diseases hospitalisation, management and mortality in Switzerland

Open Heart
2023-03 | Journal article
DOI: 10.1136/openhrt-2023-002259
Contributors: Ko Ko Maung; Pedro Marques-Vidal
Source: check_circle
Crossref

Peer review (1 review for 1 publication/grant)

Review activity for European journal of preventive cardiology. (1)
How many people are using ORCID?